Donovan Joanne M. — SEC Form 4 filings
SEC reporting owner CIK 1644087. 12 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-05-03 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 10 filings — 174,922 shares, $5,709,468 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 50,000 shares @ $38.57 ($1,928,400) in Edgewise Therapeutics, Inc., filed 2026-05-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | CMO | 12 | — | 16 legs · 174,922 sh · $5,709,468 | 25 |
Form 4 filings — Donovan Joanne M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4/A | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,781 @ $0 · Option exercise (M): 7,031 @ $0 · Sale (S): 2,839 @ $43.78 · Sale (S): 2,779 @ $43.71 · Sale (S): 104 @ $44.43 · Sale (S): 800 @ $44.52 · +5 more | EDGAR |
| 2026-05-05 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Sale (S): 5,230 @ $31.29 · Option exercise (M): 50,000 @ $7.08 · Sale (S): 50,000 @ $38.57 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 28,662 @ $7.08 · Sale (S): 28,662 @ $32.31 · Option exercise (M): 28,662 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 21,338 @ $7.08 · Sale (S): 21,338 @ $32.12 · Option exercise (M): 21,338 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Sale (S): 9,623 @ $30.98 · Sale (S): 6,735 @ $30.98 | EDGAR |
| 2025-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,781 @ $0 · Sale (S): 2,862 @ $13.39 · Option exercise (M): 5,781 (derivative) @ $0 · Grant/award (A): 28,125 (derivative) @ $0 · Grant/award (A): 168,750 (derivative) @ $0 | EDGAR |
| 2025-05-07 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 10,417 @ $0 · Sale (S): 5,187 @ $16.45 · Option exercise (M): 10,417 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 25,000 @ $7.08 · Sale (S): 25,000 @ $27.63 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-09-24 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Sale (S): 7,162 @ $28.29 | EDGAR |
| 2024-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 138,750 (derivative) @ $0 · Grant/award (A): 23,125 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 10,417 @ $0 · Sale (S): 3,682 @ $18.91 · Option exercise (M): 10,417 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1644087 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →